Significance of measurement of serum trough level and anti‐drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMO... von Nakase, H., Motoya, S., Matsumoto, T., Watanabe, K., Hisamatsu, T., Yoshimura, N., Ishida, T., Kato, S., Nakagawa, T., Esaki, M., Nagahori, M., Matsui, T., Naito, Y., Kanai, T., Suzuki, Y., Nojima, M., Watanabe, M., Hibi, T., Andoh, Akira, Ashida, Toshifumi, Endo, Katsuya, Endo, Yutaka, Esaki, Motohiro, Fujita, Hiroshi, Fujiya, Mikihiro, Haruma, Ken, Hibi, Toshifumi, Hiraoka, Sakiko, Hirata, Ichiro, Hisamatsu, Tadakazu, Honda, Yutaka, Iijima, Hideki, Iizuka, Bunei, Ikeya, Kentaro, Inoue, Takuya, Inoue, Shuji, Ishida, Tetsuya, Ishiguro, Yo, Ishihara, Shunji, Ito, Hiroaki, Iwakiri, Ryuichi, Kagaya, Takashi, Kanai, Takanori, Kashida, Hiroshi, Kato, Shingo, Kato, Jun, Katsurada, Takehiko, Kinjyo, Fukunori, Kobayashi, Kiyonori, Kodama, Mayumi, Kunisaki, Reiko, Kurahara, Koichi, Kurokami, Takafumi, Kyouwon, Lee, Matsuda, Koichiro, Matsueda, Kazuhiro, Matsui, Toshiyuki, Matsumoto, Takayuki, Mitsuyama, Keiichi, Mizokami, Yuji, Motoya, Satoshi, Naito, Yuji, Nakagawa, Tomoo, Nakamura, Shiro, Nakase, Hiroshi, Nojima, Masanori, Nomura, Masafumi, Ogawa, Atsuhiro, Okazaki, Kazuichi, Otsuka, Kazuaki, Sakuraba, Hirotake, Saruta, Masayuki, Sasaki, Makoto, Shirai, Takayuki, Suga, Tomoaki, Sugimura, Kazuhito, Sugiyama, Toshiro, Suzuki, Yasuo, Takeshima, Fuminao, Tamaki, Hiroyuki, Tanaka, Shinji, Tanida, Satoshi, Tominaga, Keiichi, Tomizawa, Taku, Watanabe, Kenji, Watanabe, Mamoru, Yamamoto, Shojiro, Yamashita, Masaki, Yoshida, Atsushi, Yoshimura, Naoki

Volltext

P562 Web-based questionnaire survey about self-management for patients with Inflammatory Bowel Disease in Japan von Nagahori, M, Imai, T, Tairaka, A

Volltext

P157 Serial daily recording of patient-reported outcomes (PRO2) might predict treatment change in the patients with Ulcerative Colitis von Tsuchiya, K, Nagahori, M, Hanazawa, R, Sasaki, M, Sato, H, Hirakawa, A, Anzai, T, Takahashi, K, Kobayashi, Y, Hibiya, S, Takenaka, K, Watanabe, M

Volltext

Controlling molecular motion on the surface by electric field gradient during molecular beam epitaxy of liquid crystal ultrathin films von Shimada, T., Nagahori, M., Koma, A.

Volltext

P664 Analysis of Clinical Trial Screen Failures in IBD: Real World Results from the IOIBD von Vieujean, S, Lindsay, J O, Rubin, D, D’Amico, F, Ahuja, V, Silverberg, M S, Sood, A, Yamamoto-Furusho, J K, Nagahori, M, Watanabe, M, Koutroubakis, I E, Foteinogiannopoulou, K, Walsh, A, Outtier, A, Abreu, M T, Dubinsky, M, Siegel, C, Louis, E, Dotan, I, Reinisch, W, Danese, S, Peyrin-Biroulet, L

Volltext

P101 Simple five-point classification of MR enterocolonography for Crohn’s disease based on enteroscopic findings von Fujii, T, Kitazume, Y, Takenaka, K, Suzuki, K, Motobayashi, M, Saito, E, Nagahori, M, Ohtsuka, K, Watanabe, M

Volltext

P158 Comparison of three endoscopic scores for prediction of relapse risk in ulcerative colitis von Horita, N, Saito, E, Motobayashi, M, Suzuki, K, Takenaka, K, Shimizu, H, Fujii, T, Nagahori, M, Ohtsuka, K, Watanabe, M

Volltext

P461 Intolerance to 5-aminosalicylate is a risk of poor prognosis in ulcerative colitis patients von Fujii, T, Hibiya, S, Maeyashiki, C, Saito, E, Takenaka, K, Motobayashi, M, Shimizu, H, Nagahori, M, Ohtsuka, K, Kurosaki, M, Yauchi, T, Watanabe, M

Volltext

DOP24 Japan prospective multicenter study for optimization of COVID-19 vaccinations based on the immune response and safety profile in Inflammatory Bowel Disease patients: Interim... von Watanabe, K, Hisamatsu, T, Nakase, H, Nagase, K, Matsuura, M, Aoyama, N, Kobayashi, T, Sakuraba, H, Yokoyama, K, Nishishita, M, Esaki, M, Hirai, F, Nagahori, M, Nanjo, S, Omori, T, Tanida, S, Yokoyama, Y, Moriya, K, Maemoto, A, Handa, O, Ohmiya, N, Shinzaki, S, Kato, S, Tanaka, H, Uraoka, T, Takatsu, N, Suzuki, H, Takahashi, K, Umeno, J, Mishima, Y, Tsuchida, K, Fujiya, M, Hiraoka, S, Yamamoto, S, Saruta, M, Nojima, M, Andoh, A

Volltext

Assessment of body composition in patients with crohn’s disease using bioelectrical impedance analysis von Saito, K., Ota, K., Nagahori, M., Fujii, T., Takenaka, K., Ohtsuka, K., Ithui, Y., Shinohara, N., Matsushita, Y., Mineki, M., Okamoto, R.

Volltext

DOP39 The first prospective, multicentre, randomised controlled trial on discontinuation of infliximab in ulcerative colitis in remission; endoscopic normalisation does not guarant... von Kobayashi, T, Motoya, S, Nakamura, S, Yamamoto, T, Nagahori, M, Tanaka, S, Hisamatsu, T, Hirai, F, Nakase, H, Watanabe, K, Matsumoto, T, Tanaka, M, Abe, T, Suzuki, Y, Watanabe, M, Hibi, T

Volltext

P256 Correlation of fecal calprotectin levels with endoscopic severity evaluated with balloon-assisted endoscopy in patients with Crohn's disease von Matsuoka, K., Iwamoto, F., Kimura, M., Takenaka, K., Fujii, T., Nagahori, M., Enomoto, N., Ohtsuka, K., Watanabe, M.

Volltext

DOP32 Withdrawal of thiopurines in Crohn’s disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2) von Hisamatsu, T, Kato, S, Kunisaki, R, Matsuura, M, Nagahori, M, Motoya, S, Esaki, M, Fukata, N, Inoue, S, Sugaya, T, Sakuraba, H, Hirai, F, Watanabe, K, Kanai, T, Naganuma, M, Nakase, H, Suzuki, Y, Watanabe, M, Hibi, T, Nojima, M, Matsumoto, T

Volltext

P541 Clinical factors associated with discontinuation of combo or monotherapy for Crohn’s disease: A sub-analysis of a prospective randomised clinical trial (DIAMOND study) von Hisamatsu, T, Matsumoto, T, Watanabe, K, Nakase, H, Motoya, S, Yoshimura, N, Ishida, T, Kato, S, Nakagawa, T, Esaki, M, Nagahori, M, Matsui, T, Naito, Y, Kanai, T, Suzuki, Y, Nojima, M, Watanabe, M, Hibi, T

Volltext

P325 Use of proton pomp inhibitor and upper gastrointestinal symptoms in IBD patients von Nagahori, M., Fujii, T., Saito, E., Ohtsuka, K., Watanabe, M.

Volltext

Monolayer films of liquid crystal 12CB grown by molecular beam deposition on cleaved surfaces of alkali halides von Shimada, T., Nagahori, M., Koma, A.

Volltext

DOP071 Comparison of endoscopic responses to adalimumab monotherapy and combination therapy with azathioprine in patients with Crohn's disease: a sub-analysis of DIAMOND trial von Watanabe, K., Matsumoto, T., Motoya, S., Hisamatsu, T., Nakase, H., Yoshimura, N., Ishida, T., Kato, S., Nakagawa, T., Nagahori, M., Esaki, M., Matsui, T., Naito, Y., Kanai, T., Suzuki, Y., Nojima, M., Watanabe, M., Hibi, T.

Volltext

P523 Association between pharmacokinetics of adalimumab and disease outcome in Japanese patients with biologics naïve Crohn's disease: a subanalysis of DIAMOND trial von Motoya, S., Nakase, H., Matsumoto, T., Watanabe, K., Hisamatsu, T., Yoshimura, N., Ishida, T., Kato, S., Nakagawa, T., Nagahori, M., Esaki, M., Matsui, T., Naito, Y., Kanai, T., Suzuki, Y., Nojima, M., Watanabe, M., Hibi, T.

Volltext

P258 Comparing MR enterocolonography to enteroscopy in Crohn's disease, especially focusing on small intestinal findings von Takenaka, K., Ohtsuka, K., Kitazume, Y., Nagahori, M., Fujii, T., Saito, E., Watanabe, M.

Volltext

FTY720 suppresses the development of colitis by modulating the trafficking of colitogenic CD4+ T cells in bone marrow von Fujii, T, Kanai, T, Tomita, T, Nemoto, Y, Totsuka, T, Naganuma, M, Nagahori, M, Watanabe, M

Volltext